Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Allergy Therapeutics (AGY)
Share Price: 14.00p Change Today:  0.000p  Market Cap: 89.06m

AGY Overview

Allergy Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 14.00p per share. In the last year Allergy Therapeutics's share price has ranged from 13.75p to 31.75p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AGY Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-14 41.96 1.08 0.16p 93.8 6.7 +14% n/a 0.0%
30-Jun-15 43.00 0.65 0.02p 1,093.7 n/a -88% n/a 0.0%
30-Jun-16 48.51 (12.06) (2.29)p n/a n/a n/a n/a 0.0%
30-Jun-17 64.14 (2.48) (0.42)p n/a n/a n/a n/a 0.0%
30-Jun-18 68.35 (7.53) (1.27)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AGY Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 73.84 (8.40) (1.36)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

AGY Company Announcements

Holdings in Company 29-Nov-2018 17:59 RNS
Result of AGM 27-Nov-2018 13:12 RNS
AGM Trading Update 27-Nov-2018 07:00 RNS

Latest AGY Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Price Data

Currency UK Pounds
Share Price 14.00p
Change Today 0.000p
% Change 0.00 %
Volume 0
10-Dec-18 Close 14.00p
Shares Issued 636.17m
Market Cap 89.06m
Year End 30-Jun-18

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

CEO Manuel Llobet
Finance Director Nicolas Wykeman